Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984082 · ClinicalTrials.gov registry record
Checklist for AI in Medical Imaging (CLAIM) Consensus Panel
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 72
- Enrollment target
NCT05984082: Completed study, sponsored by University of Pennsylvania.
NCT05984082 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05984082 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The investigators will revise the Checklist for AI in Medical Imaging (CLAIM) guideline using Delphi consensus methods. An international panel of physicians, researchers, and journal editors with expertise in AI in medical imaging -- including radiology, pathology, dermatology, GI endoscopy, and ophthalmology -- will complete up to 3 web-based surveys. Participants who complete all survey rounds will be credited as contributors on resulting publications.
Primary Outcome
potential revision of the CLAIM guidelines through Delphi consensus process.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2024-05-01 |
What the finished NCT05984082 record still lists
NCT05984082 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05984082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05984082 about?
NCT05984082 is a clinical study titled "Checklist for AI in Medical Imaging (CLAIM) Consensus Panel". The investigators will revise the Checklist for AI in Medical Imaging (CLAIM) guideline using Delphi consensus methods. An international panel of physicians, researchers, and journal editors with expertise in AI in medical imaging -- including radiology, pathology, dermatology, GI endoscopy, and oph...
What is the current status of trial NCT05984082?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2023-08-01. Estimated completion is 2024-05-01.
Who is sponsoring clinical trial NCT05984082?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI